Anzeige
Mehr »
Donnerstag, 15.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 936853 | ISIN: US28176E1082 | Ticker-Symbol: EWL
Tradegate
15.05.25 | 16:01
68,70 Euro
0,00 % 0,00
Branche
Pharma
Aktienmarkt
S&P 500
1-Jahres-Chart
EDWARDS LIFESCIENCES CORPORATION Chart 1 Jahr
5-Tage-Chart
EDWARDS LIFESCIENCES CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
68,7068,8816:13
68,6468,8816:14

Aktuelle News zur EDWARDS LIFESCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiDo Wall Street Analysts Like Edwards Lifesciences Stock?5
DiPiper Sandler raises Edwards Lifesciences target to $833
08.05.Edwards Lifesciences Corp - 8-K, Current Report14
06.05.Edwards Lifesciences Corp - 10-Q, Quarterly Report10
01.05.P/E Ratio Insights for Edwards Lifesciences7
01.05.Edwards Lifesciences Says FDA Approved TAVR Therapy For Asymptomatic Severe Aortic Stenosis261WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) Thursday said that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy,...
► Artikel lesen
01.05.FDA genehmigt TAVR-Therapie von Edwards Lifesciences9
24.04.Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens10
EDWARDS LIFESCIENCES Aktie jetzt für 0€ handeln
24.04.This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday5
24.04.Stifel maintains Edwards Lifesciences stock with $90 target8
24.04.Piper Sandler raises Edwards Lifesciences stock to Overweight25
24.04.Edwards Lifesciences outlines 2025 growth, targets $5.7B-$6.1B in sales21
23.04.Edwards Lifesciences Corp. Reveals Climb In Q1 Profit294WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) revealed a profit for its first quarter that increased from the same period last yearThe company's earnings came in at $363.6 million,...
► Artikel lesen
23.04.Edwards Lifesciences Delivers In-Line Sales, Narrow Profit Beat12
23.04.Edwards Lifesciences Corp - 8-K, Current Report4
22.04.A Look at Edwards Lifesciences' Upcoming Earnings Report15
17.04.Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings12
14.04.Edwards Lifesciences Corporation: Edwards SAPIEN M3 Receives CE Mark, Becoming World's First Transfemoral Transcatheter Mitral Valve Replacement System371Edwards Lifesciences Corporation (NYSE: EW) today announced the company's SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe...
► Artikel lesen
11.04.Edwards Lifesciences Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)7
10.04.Edwards Lifesciences' Quarterly Earnings Preview: What You Need to Know6
Seite:  Weiter >>
80 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1